The painful vaso-occlusive crises (VOC) that characterize sickle cell disease (SCD) progress over hours from the asymptomatic steady-state. SCD patients report that VOC can be triggered by stress, cold exposure, and, pain itself. We anticipated that pain could cause neural-mediated vasoconstriction, decreasing regional blood flow and promoting entrapment of sickle cells in the microvasculature. Therefore, we measured microvascular blood flow in the fingers of both hands using plethysmography and laser-Doppler flowmetry while applying a series of painful thermal stimuli on the right forearm in 23 SCD patients and 25 controls. Heat pain applied to one arm caused bilateral decrease in microvascular perfusion. The vasoconstriction response started before administration of the thermal pain stimulus in all subjects, suggesting that pain anticipation also causes significant vasoconstriction. The time delay between thermal pain application and global vasoconstriction ranged from 5 to 15.5 seconds and increased with age (P < .01). Although subjective measures, pain threshold and pain tolerance were not different between SCD subjects and controls, but the vaso-reactivity index characterizing the microvascular blood flow response to painful stimuli was significantly higher in SCD patients (P 5 .0028). This global vasoconstriction increases microvascular transit time, and may promote entrapment of sickle cells in the microvasculature, making vaso-occlusion more likely. The rapidity of the global vasoconstriction response indicates a neural origin that may play a part in the transition from steady-state to VOC, and may also contribute to the variability in VOC frequency observed in SCD patients.
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| I N TR ODU C TI ON
Sickle cell disease (SCD) is an inherited blood disorder resulting from the substitution of the amino acid valine at the sixth position of the b-globin chain to a glutamine, forming sickle hemoglobin (HbS). [1] [2] [3] HbS, unlike normal hemoglobin, polymerizes in the deoxy-state causing red blood cells (RBC) to become rigid and obstruct microvascular blood flow. 4 Chronic, intermittent microvascular occlusion produces episodes of excruciating pain, progressive organ damage and premature death. 5, 6 There is tremendous variability in the frequency of vaso-occlusive crises (VOC) among SCD patients who have the same hemoglobin genotype. Neither the cause of this variability, nor the triggers for transformation from steady state to VOC are fully understood.
SCD patients report that pain usually starts in a local region of the body, and then either intensifies and spreads, or resolves on its own.
This transition from steady state to VOC evolves over minutes to hours. Much of the SCD literature regarding the causes of VOC has focused on the role of inflammation, 7-10 cellular adhesion, [11] [12] [13] [14] [15] [16] and nitric oxide depletion that all affect blood flow in the postcapillary venules and increase the probability of VOC. [17] [18] [19] [20] However, the time course of symptom development and the regional nature of the onset do not seem consistent with these processes being the immediate triggers of VOC.
Decreased regional blood flow causing RBC retention in the microvasculature was proposed in the 70s by Eaton 30 These data suggest that SCD patients have autonomic hyperresponsiveness, [31] [32] [33] and that autonomic imbalance may play a role in the genesis of VOC.
We hypothesized that pain may cause neural-mediated vasoconstriction, increasing HbS-RBC transit time in the microvasculature, culminating in the development of clinically apparent VOC, which in turn results in more pain. Moreover, we anticipated that there would be a substantial individual variability in the neural-mediated vasoconstriction response to pain, and that this might contribute to some of the well-known variability in VOC frequency among SCD patients with the same hemoglobin genotype.
To address this hypothesis, we developed a novel methodology to objectively quantify regional microvascular blood flow as a physiological biomarker for neural response to thermal pain in SCD patients and controls. Because of the enhanced vasoconstriction response to sigh, 28 and cardiovascular autonomic dysfunction described in SCD patients 34 as well as the possible role of parasympathetic withdrawal in propensity to VOC, 31 we also assessed cardiac autonomic balance in response to thermal pain.
The study was carried out under the auspices of a research protocol approved by the Committee on Human Investigation at Children's Hospital Los Angeles (CHLA). SCD patients who were either stable on chronic transfusion, or not on chronic transfusion were recruited from the population of patients in the hemoglobinopathy center at CHLA.
Non-SCD individuals were recruited from patient's families and friends as race-matched controls. The characteristics of the subjects are summarized in Supporting Information Table S1 . Sixteen SCD patients were chronically transfused, and 4 of the 7 non-transfused patients were treated with hydroxyurea. Twenty-two SCD patients were homozygous (HbSS). One patient S-b 0 thalassemia patient was included with the SS subjects in the analysis. Among the controls, 14 participants had sickle trait (HbAS) and 11 had normal hemoglobin (HbAA). Participants were eligible if they were 13 years of age or older, and competent to understand the consent and follow instructions.
| Prestudy procedure
All studies were performed in the morning. To minimize any external effects of the participants' autonomic responses, participants were asked to refrain from caffeine intake and avoid heavy physical exercise on the day of the testing.
Participants were asked to fill out Pain Anxiety Symptoms Scale
Questionnaire or Children-Pain Anxiety Symptoms Scale Questionnaire to determine their anxiety level to pain specifically. [35] [36] [37] This was done on the study day, prior to the pain and autonomic testing.
Medical history and a blood sample were obtained prior to testing.
Standardized instructions and a short demonstration were given to participants to familiarize them with the instrumentation and sensory testing procedures.
| Experimental protocol
Measurements were carried out in a quiet, dimmed light, temperaturecontrolled room where the participant rested comfortably at an approximately 45-degree angle on a cushioned chair with arm and leg supports.
After the monitoring devices were connected, the participant was instructed to rest quietly for 15 minutes to allow all signals to stabilize before any recordings were made. The thermal pain was introduced using Medoc Thermal Neurosensory Analyzer (TSA-II, 38 ) through a thermode attached along the ventral side of the participant's right forearm.
Outputs from the thermal neurosensory analyzer and the physiological sensors were connected to a multichannel analog to digital converter (BIOPAC system-AcqKnowledge data acquisition software) to measure the change in temperature during pain administration and the change in response signals with millisecond time accuracy.
When the signals were stabilized, a 5-minute baseline recording was made followed by administration of the pain task during which the participant received 6 thermal pain pulses that were separated by 30 seconds. Figure 1 shows the raw data recording from a typical experiment and the key times of data analysis. Only the responses measured in the hand opposite to the pain stimulus are shown. The temperature was automatically increased gradually by 18C/second from the baseline thermode temperature (328C), and the participant was instructed to say "pain" when the heat was perceived as painful, halting the stimulus and rapidly resetting the thermode temperature to 328C with a return rate of 108C/second. This was repeated two more times, and the average temperature of first three thermal pain pulses was considered as the "pain threshold." This was repeated except the participant was instructed to say "stop" when the pain was perceived as intolerable. The average temperature of the last three thermal pain pulses was considered as "pain tolerance."
One minute before the pain task, the study operator verbally noti- There were no crises or adverse events caused by these procedures.
| Signal processing and analysis parameters
Recorded data from all devices were exported for processing and analysis using a locally developed data browser programed in MATLAB. Cardiac autonomic balance in response to thermal pain was assessed by analysis of heart rate variability evaluated by stationary spectral analysis of beat-to-beat variability (R-to-R interval), as we previously described, 28, 29 and by the mean and standard deviation of the R-to-R interval during baseline, verbal instruction, and pain task.
Low frequency power of heart rate variability (LFP; 0.04-0.15 Hz) reflects a combination of cardiac sympathetic and parasympathetic activity 41 while high frequency power of heart rate variability (HFP;0.15-0.4 Hz) reflects parasympathetic activity. [41] [42] [43] Mean R-to-R interval represents change in heart rate and the standard deviation of the R-to-R interval represents total heart rate variability.
| Statistical analysis
All continuous variables output from the signal processing algorithms in the data browser were expressed as mean and standard deviation, whereas all categorical variables were expressed as number (n), and percentage (%). 
| R ESU L TS
Patient demographics are summarized in Supporting Information Table S1 . The two groups of participants were reasonably well balanced for gender, but not for age. HbS concentrations were measured for each participant; however, it was not included in the analysis because it served only as a surrogate for diagnosis. Analyses within the controls (SCT versus healthy) and the SCD group (transfused versus non-transfused) were performed and no differences were found. Based on these analyses, sickle trait subjects were grouped with non-trait controls, and transfused and non-transfused SCD subjects were grouped together. The magnitude of the vasoconstriction response to pain was clearly different between SCD patients and controls (overall P 5 .0077, vaso-reactivity index P 5 .0028) after controlling for age and gender in the multivariate analysis (Table 1) . Vaso-reactivity was significantly higher in SCD patients, indicating that those patients had a greater blood flow change in response to thermal pain than controls (Figure 2A) . However, the apparent shorter time between stimulus and vasoconstriction seen in univariate analysis (Supporting Information Table S2 ) was due to the older age of controls. The vasoconstriction response to pain was delayed by a mean of 9.9 seconds, and showed significant variability among participants (vasoconstriction delay ranged 5 to 15.5, Figure 2B) . Similarly, the vaso-reactivity index displayed variability among participants with a mean vasoconstriction response index of 0.99 arbitrary units (range 20.06 to 1.8, Figure 2C ).
| Vasoconstriction in response to thermal pain is greater in SCD subjects
Gender did affect vaso-reactivity, but had no effect in the overall model (Table 1 ). Of note, there was no difference in the pain threshold and pain tolerance temperatures between SCD patients and controls. were not dependent on age or gender.
| Pain anticipation significantly decreases microvascular blood flow in SCD and control subjects
We expected that anxiety might modulate the responses to the pain stimuli, and assessed the participant's anxiety with standard anxiety questionnaires on the day of each study. The mean pain anxiety score was significantly higher in SCD patients than in controls (P 5 .009) (Supporting Information Table S1 ). However, there was no association between the pain anxiety scores and vaso-reactivity or vasoconstriction delay, or any effect of age or gender.
| Thermal pain and pain anticipation alter cardiac autonomic balance
The results of the heart rate variability analysis reflecting cardiac autonomic function during baseline, verbal instruction, and pain task are presented in Supporting Information Figure S1 . Mean R-to-R interval, standard deviation and low frequency power dropped significantly during verbal instruction, indicating that fear of pain increased the heart rate and decreased total heart rate variability (P < .001). However, high frequency power did not change significantly. The combination of increase in heart rate and decrease in low frequency power suggest parasympathetic withdrawal that resulted in loss of heart rate variability during the pain fear period with partial recovery during the pain administration. While fear of pain during verbal instruction and pain itself had a substantial effect on autonomic balance, the response in SCD patients was not different from that in controls. Sickle cell disease is characterized by the rapid onset of acute, painful vaso-occlusive episodes that, as patients often state, are triggered by emotional stress, cold temperature, or pain itself. These acute VOC, which start in a local region of the body, occur on a background of progressive, chronic vascular disease that is related to inflammation, [7] [8] [9] [10] vascular shear stress, 14, 15 and toxic endothelial damage. 44 Heat pain has been studied in many settings, including SCD, but the participants' subjective perception of pain was used as a measurement of pain sensitivity. 47, 48 Those studies showed that the perception of pain differed in SCD from controls. In contrast, we found that pain We expected to see a shorter delay time between stimulus and onset of response in SCD patients because of the autonomic hypersensitivity suggested by sigh-induced vasoconstriction in SCD patients, 28 and hypersensitivity to pain in sickle mice in direct neuron recordings. 49 However, while this was apparent in the univariable analysis (Supporting Information Table S2 ), the difference in delay between pain and vasoconstriction in our data was related to participant's age (P 5 .01) in the multivariable model, which is consistent with the known slowing of nerve conduction velocity with increasing age.
50,51
The vasoconstriction response to pain happened in both contralateral and ipsilateral hands, indicating that this effect is neurallymediated and global, and it is not due to a local effect of the heat. This response is due in part to an autonomic response, but could also be influenced by end-organ sensitivity to neural stimulation. Certainly, nitric oxide depletion can impair arteriolar dilation, and endothelin-1, which is elevated in SCD, can promote vasoconstriction. [52] [53] [54] This may explain the increased responsiveness seen in SCD. However, the timing of the response in our experiments and the fact that it occurred within a few seconds contralateral to the stimulus supports a neural trigger. The calculated change in blood flow with respect to change in temperature or vasoconstriction responsiveness was also quite variable among participants, but was significantly higher in SCD patients (Figure 2A , P 5 .0028), indicating that SCD patients might have autonomic hyper-responsiveness and/or end-organ hypersensitivity to neural stimulation. 28, 55 A dramatic decrease in perfusion was observed in response to verbal instruction-induced stress when participants were told they would soon feel pain. It was evident from inspection of the raw data that there were dramatic differences among participants with respect to the duration of "fear"-induced vasoconstriction, but no difference could be detected between SCD and controls. Although SCD patients had much higher pain anxiety scores, the prestudy questionnaire scores did not correlate with perfusion changes. Nonetheless, the profound vasoconstriction observed with anxiety/stress is consistent with clinical observation that social and physical stress can trigger VOC, potentially through neurally-mediated vasoconstriction. Analysis of variance; overall P-value: P < .0001. The response in SCD did not differ from control Interestingly, patterns of microvascular flow in SCD were noted to differ from control in early studies using laser-Doppler, though the mechanism was not understood. [56] [57] [58] This was postulated as a target for treatment 59 and in fact, the vasoactive agent buflomedil was shown to improve microvascular flow. 60 The connection of these flow oscillations to autonomic regulation and the autonomic hypersensitivity of SCD subjects did not become clear until the observation that SCD subjects vasoconstrict in response to sigh at a much greater rate than normal controls. 28 While the precise timing of the respiratory response to a minimal respiratory stimulus like a sigh was reported recently, the fact that blood flow decreased with deep respiration was reported in the later 1800s. 61 Based on this autonomic vascular sensitivity, we expected to see differences in cardiac autonomic balance in response to pain and there were clear changes between baseline, verbal instruction, and pain task in all subjects. However, there were no measureable differences between SCD patients and controls. Unlike with sigh-induced vasoconstriction where the stimulus was less than maximal, 28 we suspect that the pain stimuli used here were too intense to detect subtle differences that might be due to altered autonomic responsiveness.
Our data strongly show that thermal pain and fear of pain induce significant rapid global decrease in microvascular blood flow. This response is mediated through the ANS and occurs in SCD subjects and controls although the change in blood flow per unit change in thermal stimulus is greater in SCD. Furthermore, the fact that both SCD and control subjects vaso-constrict in response to pain does not diminish the importance of these findings with respect to the physiology of SCD. Increasing microvascular transit time will make microvascular occlusion more likely with Hb-S. 21, 23 These same vascular reactivity parameters may also have significance in disorders like angina. While all vascular beds are not interchangeable, change in flow measured by plethysmography in the fingertip in response to mental stress correlations strongly with cardiac perfusion measured at the same time in subjects with coronary artery disease. 62 The methodology presented here offers a way to objectively quantify these physiological responses to pain using microvascular perfusion as a biomarker rather than the subjective report of a pain scale reading. Importantly, this biophysical biomarker affects the RBC transit time and is thus directly related to the mechanism of microvascular occlusion in SCD. 21, 23 The cross- Regional microvascular perfusion is an important biomarker that will likely help us to understand the SCD physiology and may serve as a measurable therapeutic target.
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